A randomized comparison of health-related quality of life outcomes of dolutegravir versus efavirenz-based antiretroviral treatment initiated in the third trimester of pregnancy

INTRODUCTION: Evidence on health-related quality of life (HRQoL) outcomes is limited for new antiretroviral therapies (ART). Dolutegravir-based treatment is being rolled out as the preferred first-line treatment for HIV in many low- and middle-income countries. We compared HRQoL between treatment-na...

Descripción completa

Detalles Bibliográficos
Autores principales: Ochanda, Perez Nicholas, Lamorde, Mohammed, Kintu, Kenneth, Wang, Duolao, Chen, Tao, Malaba, Thokozile, Myer, Landon, Waitt, Catriona, Reynolds, Helen, Khoo, Saye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9172107/
https://www.ncbi.nlm.nih.gov/pubmed/35672853
http://dx.doi.org/10.1186/s12981-022-00446-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9172107/
https://www.ncbi.nlm.nih.gov/pubmed/35672853
http://dx.doi.org/10.1186/s12981-022-00446-3

Ejemplares similares